Key facts
- TidalSense’s last known valuation is $18.0M (Aug 2024).
- It has raised $17.9M; the latest was Later Stage VC ($980K) in Mar 2026.
- Notable investors include Innovate UK, BGF (Financial Services), Arm, Asthmaandlung UK, Card Sound Capital — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for TidalSense
- ·The full record, as it builds
Funding rounds
No funding rounds for TidalSense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TidalSense
Developer of AI-driven respiratory diagnostic and monitoring technologies designed to build novel sensor tools that can detect changes in lung function. The company device converts sensor data into respiratory biomarkers in near-real time and is managed automatically as it is four-generation-connected and has handheld, portable, and patient acceptability, enabling healthcare providers and patients to achieve faster, more accurate diagnoses and better management of respiratory health.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2013
- Employees
- 30
- Website
- tidalsense.com/
- Ownership
- Privately Held (backing)
TidalSense doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TidalSense shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TidalSense in its N-PORT filings yet. We sweep new filings monthly.